New guidelines for the treatment of type 2 diabetes have recently been published by the American Diabetes Association.
This article was aimed at analyzing these recommendations in light of recent scientific data, including cardiovascular results.
Type 2 diabetes, treatment, macroangiopathy, GLP-1 agonists, SGLT-2 inhibitors
What does this article bring up for us?
The therapeutic approach for type 2 diabetes is very well structured. However, a new treatment algorithm has recently been published, partly basing on the cardiovascular effects of newer and older antihyperglycemic agents.